French firm wins funds for work on HIV/AIDS, obesity

04/10/2013 | GenomeWeb Daily News (free registration)

Theradiag, an in vitro diagnostics and theranostics company based in France, will use $1.6 million from Oséo to design test kits as part of its collaborative effort with Splicos and the French National Center for Research and Science. The project, called CaReNA, is aimed at developing diagnostic tests and RNA-targeting therapeutics for obesity and HIV/AIDS.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC